Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair loss while on Mounjaro is real, but it almost certainly isn't the medicine attacking your hair follicles. Most people who notice thinning during tirzepatide treatment are experiencing a well-documented biological response to rapid weight loss called telogen effluvium — a temporary disruption to the hair-growth cycle, not permanent damage. Mounjaro itself is not thought to be directly toxic to hair. That distinction matters, because the path forward looks very different depending on which one you're dealing with. These are prescription-only medicines, and your prescriber can help you work through what's going on for you specifically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing worth setting straight: Mounjaro does not directly damage hair follicles. The NHS patient information on tirzepatide lists hair loss among reported side effects, but the mechanism behind it is physiological stress — specifically, the kind that a body experiences when it loses weight quickly. Hair follicles are exquisitely sensitive to changes in nutritional status and energy availability. When the body perceives a significant caloric shift, some follicles exit their active growth phase early and enter a resting phase. Several weeks or months later, those hairs shed all at once, which is when people notice the change.
This process, telogen effluvium, has been documented after bariatric surgery, crash diets, serious illness, and other rapid-weight-loss events long before GLP-1 medicines existed. It is the weight loss doing the heavy lifting here, not a chemical property of tirzepatide. That does not mean the shedding is trivial or that you should ignore it, but it does mean the response to it is primarily nutritional and time-related, not about stopping your treatment.
One practical note: if you want to understand why hair loss happens with Mounjaro and what the experience typically looks like, the timing of when people notice their hair changing often catches them off guard. Because the lag between the triggering event and visible shedding can be two to four months, some people connect the hair loss to a dose increase or a stressful week rather than to the period of most rapid weight loss that came before it. Worth keeping in mind if you're trying to work out what caused it.
A few factors make telogen effluvium more likely or more pronounced. The speed of weight loss matters: a sharper caloric deficit tends to produce a stronger physiological stress signal. Protein adequacy is the single most important nutritional lever. Hair is largely keratin, a protein, and when overall food intake drops substantially, protein is sometimes the casualty. Aiming for adequate protein at every meal while on tirzepatide is not just good for muscle preservation, it gives your follicles the building blocks they need.
Iron deficiency is another common contributor and is frequently missed. Women in particular may find that a period of reduced eating pushes borderline iron stores into frank deficiency, which compounds shedding. A simple blood test with your GP can rule this in or out. Zinc, ferritin and biotin levels are sometimes implicated too, though supplementing biotin in the absence of a confirmed deficiency has limited evidence behind it.
For more practical strategies (including specific nutritional approaches and timing considerations) the page on preventing hair loss while on Mounjaro goes into more detail. The short version: eat enough protein, keep up with blood tests your GP recommends, and give your body time.
Telogen effluvium is generally self-limiting. As weight stabilises and nutrition improves, regrowth usually begins within six months of the shedding peak, most people see clear improvement within a year. What you are watching for is anything that falls outside that pattern.
Get in touch with a clinician promptly if your hair loss is patchy or asymmetrical rather than diffuse; if there is any redness, scaling or tenderness on the scalp; if eyebrows or eyelashes are affected; if you are losing hair elsewhere on the body; or if there is no sign of slowing after many months of stable weight. These features suggest a different diagnosis altogether, alopecia areata, thyroid dysfunction, or another condition that needs its own investigation and treatment.
The MHRA's Yellow Card scheme allows anyone to report suspected side effects from a prescription medicine. If you believe your hair loss is directly related to tirzepatide in a way that seems unusual, our page covering Mounjaro side effects and hair loss in detail may help you decide whether reporting it is appropriate, and contributing to the ongoing safety picture for the medicine is something you can do as a patient, without needing to go through a healthcare professional first.
If you are unwell in a way that goes beyond hair changes (persistent nausea, vomiting or stomach pain that won't settle) there is separate guidance on managing Mounjaro when you're ill that may be relevant.
Hair loss is one of those side effects that rarely comes up in a quick GP appointment but often weighs on people quite heavily. Our prescribers hear about it regularly. If you're on Mounjaro through nume, aftercare is available seven days a week: you don't need to wait until a scheduled review to raise a concern. The consultation is the right place to discuss your full picture (how quickly you've lost weight, what your diet looks like, whether you've had recent blood tests) because the response to hair shedding is specific to your situation, not a single protocol that fits everyone.
Our clinical team, overseen by our clinical director, reviews every case individually. If you're considering starting treatment and want to understand what to expect, Mounjaro's broader side-effect profile is worth reading before you begin. And if you haven't yet had a consultation, starting a free one is the first step, suitability and side effects are discussed as part of it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.